|
1
|
Schlumberger MJ: Papillary and follicular
thyroid carcinoma. N Engl J Med. 338:297–306. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hartl DM, Chami L, Al Ghuzlan A,
Leboulleux S, Baudin E, Schlumberger M and Travagli JP: Charcoal
suspension tattoo localization for differentiated thyroid cancer
recurrence. Ann Surg Oncol. 16:2602–2608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang TW, Shin JH, Han BK, Ko EY, Kang SS,
Hahn SY, Kim JS and Oh YL: Preoperative ultrasound-guided tattooing
localization of recurrences after thyroidectomy: Safety and
effectiveness. Ann Surg Oncol. 16:1655–1659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim MK, Mandel SH, Baloch Z, Livolsi VA,
Langer JE, Didonato L, Fish S and Weber RS: Morbidity following
central compartment reoperation for recurrent or persistent thyroid
cancer. Arch Otolaryngol Head Neck Surg. 130:1214–1216. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mathieu MC, Bonhomme-Faivre L, Rouzier R,
Seiller M, Barreau-Pouhaer L and Travagli JP: Tattooing breast
cancers treated with neoadjuvant chemotherapy. Ann Surg Oncol.
14:2233–2238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chami L, Hartl D, Leboulleux S, Baudin E,
Lumbroso J, Schlumberger M and Travagli JP: Preoperative
localization of neck recurrences from thyroid cancer: Charcoal
tattooing under ultrasound guidance. Thyroid. 25:341–346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Soprani F, Bondi F, Puccetti M and
Armaroli V: Charcoal tattoo localization for differentiated thyroid
cancer recurrence in the central compartment of the neck. Acta
Otorhinolaryngol Ital. 32:87–92. 2012.PubMed/NCBI
|
|
8
|
Wang Y, Lei K-R, He Y-P, Li XL, Ren WW,
Zhao CK, Bo XW, Wang D, Sun CY and Xu HX: Malignancy risk
stratification of thyroid nodules: Comparisons of four ultrasound
Thyroid Imaging Reporting and Data Systems in surgically resected
nodules. Sci Rep. 7:115602017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bonhomme-Faivre L, Depraetere P, Savelli
MP, Amdidouche D, Bizi E, Seiller M and Orbach-Arbouys S: Charcoal
suspension for tumor labelling modifies macrophage activity in
mice. Life Sci. 66:817–827. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biffoni M, Scipioni P and Macrina N:
Surgical treatment of differentiated thyroid cancer recurrence.
L'Endocrinologo. 10:143–148. 2009. View Article : Google Scholar
|
|
11
|
Moley JF and Wells SA:
Compartment-mediated dissection for papillary thyroid cancer.
Langenbecks Arch Surg. 384:9–15. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lundgren CI, Hall P, Dickman PW and
Zedenius J: Clinically significant prognostic factors for
differentiated thyroid carcinoma: A population-based, nested
case-control study. Cancer. 106:524–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shaha A: Treatment of thyroid cancer based
on risk groups. J Surg Oncol. 94:683–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kupferman ME, Patterson M, Mandel SJ,
LiVolsi V and Weber RS: Patterns of lateral neck metastasis in
papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg.
130:857–860. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hassanain M and Wexler M: Conservative
management of well-differentiated thyroid cancer. Can J Surg.
53:109–118. 2010.PubMed/NCBI
|
|
16
|
Shaha AR, Shah JP and Loree TR: Patterns
of nodal and distant metastasis based on histologic varieties in
differentiated carcinoma of the thyroid. Am J Surg. 172:692–694.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hay ID, Bergstralh EJ, Grant CS, McIver B,
Thompson GB, van Heerden JA and Goellner JR: Impact of primary
surgery on outcome in 300 patients with pathologic
tumor-node-metastasis stage III papillary thyroid carcinoma treated
at one institution from 1940 through 1989. Surgery. 126:1173–1181;
discussion 1181–1182. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pai SI and Tufano RP: Reoperation for
recurrent/persistent well-differentiated thyroid cancer.
Otolaryngol Clin North Am. 43353–363. (ix)2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Betka J, Mrzena L, Astl J, Nemec J, Vlcek
P, Taudy M and Skrivan J: Surgical treatment strategy for thyroid
gland carcinoma nodal metastases. Eur Arch Otorhinolaryngol. 254
(Suppl 1):S169–S174. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scheumann GF, Seeliger H, Musholt TJ, Gimm
O, Wegener G, Dralle H, Hundeshagen H and Pichlmayr R: Completion
thyroidectomy in 131 patients with differentiated thyroid
carcinoma. Eur J Surg. 162:677–684. 1996.PubMed/NCBI
|
|
21
|
Travagli JP, Cailleux AF, Ricard M, Baudin
E, Caillou B, Parmentier C and Schlumberger M: Combination of
radioiodine (131I) and probe-guided surgery for persistent or
recurrent thyroid carcinoma. J Clin Endocrinol Metab. 83:2675–2680.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rubello D, Salvatori M, Ardito G, Mariani
G, Al-Nahhas A, Gross MD, Muzzio PC and Pelizzo MR: Iodine-131
radio-guided surgery in differentiated thyroid cancer: Outcome on
31 patients and review of the literature. Biomed Pharmacother.
61:477–481. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salvatori M, Ardito G, Pelizzo MR, Mariani
G, Gross M, Al-Nahhas A and Rubello D: Treatment of local and
regional recurrences of differentiated thyroid cancer by
radio-guided surgery with iodine-131. Nucl Med Rev Cent East Eur.
9:119–124. 2006.PubMed/NCBI
|
|
24
|
Lucchini R, Puxeddu E, Calzolari F,
Burzelli F, Monacelli M, D'Ajello F, Macaluso R, Giammartino C,
Ragusa M, De Feo P, et al: Recurrences of thyroid well
differentiated cancer: Ultrasonography-guided surgical treatment.
Minerva Chir. 63:257–260. 2008.PubMed/NCBI
|
|
25
|
Duprez R, Lebas P, Marc OS, Mongeois E,
Emy P and Michenet P: Preoperative US-guided hook-needle insertion
in recurrent lymph nodes of papillary thyroid cancer: A help for
the surgeon. Eur J Radiol. 73:40–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sippel RS, Elaraj DM, Poder L, Duh QY,
Kebebew E and Clark OH: Localization of recurrent thyroid cancer
using intraoperative ultrasound-guided dye injection. World J Surg.
33:434–439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gulec SA, Eckert M and Woltering EA: Gamma
probe-guided lymph node dissection (‘gamma picking’) in
differentiated thyroid carcinoma. Clin Nucl Med. 27:859–861. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grant CS, Thompson GB, Farley DR, Richards
ML, Mullan BP and Hay ID: The value of positron emission tomography
in the surgical management of recurrent papillary thyroid
carcinoma. World J Surg. 32:708–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Borsò E, Grosso M, Boni G, Manca G,
Bianchi P, Puccini M, Arganini M, Cabria M, Piccardo A, Arlandini
A, et al: Radioguided occult lesion localization of cervical
recurrences from differentiated thyroid cancer: Technical
feasibility and clinical results. Q J Nucl Med Mol Imaging.
57:401–411. 2013.PubMed/NCBI
|
|
30
|
Molina MA, Goodwin WJ, Moffat FL, Serafini
AN, Sfakianakis GN and Avisar E: Intra-operative use of PET probe
for localization of FDG avid lesions. Cancer Imaging. 9:59–62.
2009.PubMed/NCBI
|
